We have further answered the above question, whereby exogenous intraperitoneal H2S application delays hypertension development by protecting peripheral organs, such as the kidneys, and the central brain tissue of the PVN, and by reducing oxidative stress, expression of the NF-κB pathway, PIC activity, and neuronal apoptosis. Here, SLC25A3 is linked to hypertensive disorder.